
Articles
-
3 weeks ago |
forbes.com | Seth Joseph
When the most dominant player in a market stumbles, the rest of the industry pays attention. That’s precisely what happened last month, when UnitedHealth Group - the largest Medicare Advantage insurer in the country - reported disappointing earnings and a jarring shift in tone.
-
3 weeks ago |
forbes.com | Seth Joseph
Epic Systems is perhaps the most successful health technology company in the world. Its electronic health record (EHR) platform is now used by the majority of large health systems in the U.S. Its customers are vocal in their support and are often passionate defenders of the platform’s reliability, configurability, and comprehensiveness.
-
1 month ago |
forbes.com | Seth Joseph
CVS Health last Thursday announced that its pharmacy benefit manager division will drop Eli Lilly’s Zepbound from its preferred formulary list starting July 1, 2025. Instead, CVS will prioritize coverage of Wegovy, a competing GLP-1 medication produced by Novo Nordisk.
-
2 months ago |
forbes.com | Seth Joseph
Artificial intelligence (AI) is enjoying its moment as the hottest area of venture investment, with more than flowing into the sector last year. In healthcare, AI accounted for in 2024 – and data shows to a strong start. That momentum continues today with the announcement of a $21 million Series A by Layer Health, an ambitious healthcare AI startup aiming to tackle some of the sector’s thorniest issues and overcome the industry’s biggest barriers to growth.
-
2 months ago |
forbes.com | Seth Joseph
What does a pharmaceutical company have to do with U.S. national security? Perhaps more than meets the eye, based on President Trump’s negotiating style, which often involves utilizing leverage to weaken the other side’s bargaining position. In the case at hand, President Trump has repeatedly expressed an interest in acquiring Greenland from Denmark for reasons involving national security.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →